tiprankstipranks
Trending News
More News >
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market

Knight Therapeutics (KHTRF) Financial Statements

Compare
32 Followers

Knight Therapeutics Financial Overview

Knight Therapeutics's market cap is currently $458.39M. The company's EPS TTM is $0.06565077; its P/E ratio is -112.09; Knight Therapeutics is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 450.09MC$ 371.30MC$ 328.20MC$ 293.56MC$ 243.48M
Gross ProfitC$ 150.74MC$ 174.41MC$ 152.65MC$ 138.06MC$ 115.41M
Operating IncomeC$ -2.20MC$ 7.40MC$ -2.89MC$ -2.40MC$ -5.32M
EBITDAC$ 54.37MC$ 64.38MC$ 40.90MC$ 25.26MC$ 42.59M
Net IncomeC$ -5.37MC$ 4.33MC$ -16.84MC$ -29.89MC$ 15.68M
Balance Sheet
Cash & Short-Term InvestmentsC$ 95.28MC$ 172.84MC$ 154.42MC$ 185.61MC$ 162.99M
Total AssetsC$ 1.05BC$ 963.80MC$ 945.49MC$ 1.05BC$ 991.89M
Total DebtC$ 77.91MC$ 49.46MC$ 69.09MC$ 77.70MC$ 40.96M
Net DebtC$ 1.46MC$ -30.65MC$ 10.33MC$ 6.02MC$ -45.01M
Total LiabilitiesC$ 279.03MC$ 168.69MC$ 198.62MC$ 228.98MC$ 149.87M
Stockholders' EquityC$ 767.27MC$ 795.11MC$ 746.87MC$ 825.86MC$ 842.02M
Cash Flow
Free Cash FlowC$ 68.40MC$ 4.81MC$ 25.98MC$ 14.66MC$ -179.56M
Operating Cash FlowC$ 70.30MC$ 36.28MC$ 35.94MC$ 40.48MC$ 44.62M
Investing Cash FlowC$ -84.11MC$ 16.96MC$ 29.34MC$ -63.08MC$ -105.28M
Financing Cash FlowC$ 13.01MC$ -33.54MC$ -81.00MC$ 1.76MC$ -78.31M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

Knight Therapeutics Debt to Assets

Knight Therapeutics Cash Flow

Knight Therapeutics Forecast EPS vs Actual EPS